Latest Enbrel news
Infection Risk Lower for Etanercept Vs Monoclonal Ab Rx
by modernClinician Editorial Team
For patients with rheumatoid arthritis, etanercept is associated with lower risk for general infections and tuberculosis compared with monoclonal antibody treatment, according to a meta-analysis published online Feb. 3 in the International Journal of Rheumatic Diseases.
Study Compares Effectiveness of Biologics in Psoriasis Treatment
by modernClinician Editorial Team
For patients with psoriasis, ustekinumab has the highest effectiveness over five years of treatment and adalimumab and ustekinumab more often reach a 75 percent reduction in Psoriasis Area Severity Index compared to baseline than etanercept, according to a study published online Aug. 31 in the British Journal of Dermatology.
FDA Approves Biosimilar Drug Erelzi for Rheumatoid Arthritis
by modernClinician Editorial Team
A new biological drug to treat rheumatoid arthritis and other inflammatory diseases has been approved by the U.S. Food and Drug Administration.
Editor's Recommendations
Exposure to Air Pollutants Linked to Increased RA Disease Activity 
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA 
Consensus Statements Developed for Rheumatoid Arthritis-Linked Interstitial Lung Disease 
Longer Persistence Seen With Upadacitinib Versus TNFi in Rheumatoid Arthritis Related Articles
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes .jpg)
Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Setmelanotide Beneficial in Acquired Hypothalamic Obesity Monthly Specialist Briefings
Stay Connected
